{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-005147","form_type":"8-K","ticker":"ASPN","cik":"0001145986","company_name":"ASPEN AEROGELS INC","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.445712+00:00","generated_at":"2026-05-17T17:07:40.917443+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aspen Aerogels Reports Q2 2025 Revenue of $78M, Net Loss of $9.1M, and CFO Transition","bullets":["Total revenue for Q2 2025 was $78.0 million, down from $117.8 million in Q2 2024.","Net loss was $9.1 million, including $5.9 million of restructuring and impairment charges, compared to net income of $16.8 million a year ago.","Adjusted EBITDA for Q2 2025 was $9.7 million, versus $28.9 million in the prior-year quarter.","Aspen announces a CFO transition to an internal successor during Q3 2025.","Fixed cost structure reductions are expected to drive incremental profit in the second half of 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-005147","json":"https://secwatch.observer/filing/0001171843-25-005147.json","markdown":"https://secwatch.observer/filing/0001171843-25-005147.md","text":"https://secwatch.observer/filing/0001171843-25-005147.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1145986/000117184325005147/0001171843-25-005147-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1145986/000117184325005147/f8k_080725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-17T17:07:40.917443+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}